These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24688075)

  • 1. Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.
    Martins C; Garly ML; Bale C; Rodrigues A; Njie-Jobe J; Benn CS; Whittle H; Aaby P
    J Infect Dis; 2014 Sep; 210(5):693-700. PubMed ID: 24688075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
    Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi.
    Fowlkes A; Witte D; Beeler J; Audet S; Garcia P; Curns A; Yang C; Fudzulani R; Broadhead R; Bellini WJ; Cutts F; Helfand RF
    J Infect Dis; 2011 Jul; 204 Suppl 1():S149-57. PubMed ID: 21666156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
    Rogers S; Sanders RC; Alpers MP
    J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
    Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
    J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.
    Job JS; Halsey NA; Boulos R; Holt E; Farrell D; Albrecht P; Brutus JR; Adrien M; Andre J; Chan E
    Pediatr Infect Dis J; 1991 Apr; 10(4):303-11. PubMed ID: 2062626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.
    Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
    Whittle HC; Campbell H; Rahman S; Armstrong JR
    Lancet; 1990 Oct; 336(8722):1046-8. PubMed ID: 1977029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels.
    Fisker AB; Nebie E; Schoeps A; Martins C; Rodrigues A; Zakane A; Kagone M; Byberg S; Thysen SM; Tiendrebeogo J; Coulibaly B; Sankoh O; Becher H; Whittle HC; van der Klis FRM; Benn CS; Sie A; Müller O; Aaby P
    Clin Infect Dis; 2018 May; 66(10):1573-1580. PubMed ID: 29177407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age.
    Jensen TG; Whittle H; Mordhorst CH; Pedersen IR; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Vaccine; 1994 Aug; 12(11):1026-31. PubMed ID: 7975843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
    Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
    Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
    Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
    Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
    Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.